Reply to a commentary on Swedish policy analysis for Covid-19
Health Policy Technol
.
2021 Sep;10(3):100550.
doi: 10.1016/j.hlpt.2021.100550.
Epub 2021 Jul 16.
Authors
Andrius Kavaliunas
1
,
Isis Lindfeldt
2
,
Mattias Kyhlstedt
3
Affiliations
1
Department of Clinical Neuroscience, Tomtebodavägen 18A:05, 171 77 Stockholm, Sweden.
2
Department of Sociology and Uppsala Antibiotic Center, Uppsala University, Uppsala, Sweden.
3
Synergus RWE AB, Stockholm, Sweden.
PMID:
34307010
PMCID:
PMC8282938
DOI:
10.1016/j.hlpt.2021.100550
No abstract available